Entry Detail



General Information

Database ID:exR0012395
RNA Name:RPS18
RNA Type:mRNA
Chromosome:chr6
Starnd:+
Coordinate:
Start Site(bp):33272075End Site(bp):33276511
External Links:ENSG00000231500



Disease Information

Disease Name:Down Syndrome
Disease Category:Congenital, Hereditary, and Neonatal Diseases and Abnormalities
MeSH ID:D004314
Type:Diseases Category/Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Alias:Syndrome, Down//Mongolism//47,XY,+21//Trisomy G//47,XX,+21//Down's Syndrome//Downs Syndrome//Syndrome, Down's//Trisomy 21//Trisomy 21, Mitotic Nondisjunction//Down Syndrome, Partial Trisomy 21//Partial Trisomy 21 Down Syndrome//Trisomy 21, Meiotic Nondisjunction



Expression Detail

GEO ID:GSE16176
Description:Expression profiles of amniotic fluid from human fetuses with Down syndrome and euploid controls
Experimental Design:Disease vs Control
Case Disease Type:Down Syndrome
Case Disease SubType:NA
Case Sample:Down Syndrome
Control Sample:Normal
Number of Case:7
Number of Control:7
Number of Samples:14





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
AHCY
chr20
34280268
34311802
-
AKIRIN1
chr1
38991276
39006059
+
AC015802.6
chr17
76563710
76570544
-
AC024592.3
chr19
5866171
5903787
-
ABRACL
chr6
139028745
139043302
+
ABTB2
chr11
34150987
34358010
-
ADGRL2
chr1
81306160
81992436
+
AIFM1
chrX
130129362
130165887
-
ALDOA
chr16
30064164
30070457
+
AKR1A1
chr1
45550543
45570049
+
AC005258.1
chr19
2269525
2341172
+
AFG3L2
chr18
12328944
12377227
-
ABCB7
chrX
75051048
75156732
-
AGO2
chr8
140520156
140635633
-
AASDH
chr4
56338287
56387508
-
AKT1S1
chr19
49869033
49878459
-
AC011462.1
chr19
41350853
41425001
+
ACTB
chr7
5527148
5563784
-
AEBP2
chr12
19404045
19720801
+
ACTR3
chr2
113890063
113962596
+
AAR2
chr20
36236459
36270918
+
AC008982.1
chr19
38817471
38840178
-
ACAA2
chr18
49782164
49813953
-
AC007040.2
chr2
70939318
70995336
-
ADRA2A
chr10
111077029
111080907
+
AC011005.1
chr7
129126518
129130793
+
AC023055.1
chr12
55757275
55827546
-
ACTR2
chr2
65227753
65271253
+
AC010422.3
chr19
12643831
12648397
-
AC073508.2
chr17
40627356
40665141
-
miRNA targets:NA
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC004080.6
chr7
27128969
27152561
-
AC004687.1
chr17
58330884
58332508
-
AC021078.1
chr5
149494314
149504670
-
AC040162.3
chr16
67882461
67886367
+
AC091564.7
chr11
6610883
6616594
-
AC105339.2
chr15
82752884
82757208
+
AC138089.1
chr1
248484245
248485484
-
Display:



Experiment Detail

GEO ID:GSE16176
Sample Source:Amniotic Fluid
Source Fraction:Supernatant
Platform:GPL570
Method:Microarray
Num of detected RNA Type:1
Num of detected RNAs of this Type:17063
Sample treatment protocol:NA
RNA Extract protocol:RNA was extracted from 10 mL AF with 30 mL TRIzol LS Reagent (Invitrogen, Carlsbad, CA) and 8 mL chloroform. After RNA extraction, RNA was purified and DNA was removed using the RNeasy® Maxi Kit, including the DNase step according to the manufacturer's protocol (QIAGEN, Valencia, CA). RNA was precipitated using 3M NaOAc and 100% ethanol, and 80% ethanol was added after 4 hours incubation at -20 °C. cDNA, synthesized from extracted RNA, was amplified and purified using the WT-Ovation™ Pico RNA Amplification System (NuGEN, San Carlos, CA) and the DNA Clean & Concentrator™-25 (Zymo Research, Orange, CA).
RNA library preparation protocol:biotin Samples were labeled using the FL-Ovation™ cDNA Biotin Module V2 (NuGEN, San Carlos, CA).



Reference

PMID:19474297
Title:Functional genomic analysis of amniotic fluid cell-free mRNA suggests that oxidative stress is significant in Down syndrome fetuses
Author:Slonim DK, Koide K, Johnson KL, Tantravahi U, Cowan JM, Jarrah Z, Bianchi DW
Journal:Proc Natl Acad Sci U S A. 2009 Jun 9;106(23):9425-9.
Description:To characterize the differences between second trimester Down syndrome (DS) and euploid fetuses, we used Affymetrix microarrays to compare gene expression in uncultured amniotic fluid supernatant samples.